Management of Recurrent Croup
1 other identifier
interventional
10
1 country
1
Brief Summary
Presently children who experience recurring croup symptoms receive a variety of treatments. This is because it is not clear which treatments may be best. Some children are given inhaled steroids (similar to what children with asthma use). Others are carefully watched and cautioned to avoid potential triggers (certain foods, environmental allergens, etc), and should episodes of croup recur they are treated with a short course of oral steroids. The purpose of this study is to compare two safe and clinically appropriate methods for treating recurrent croup, daily inhaled steroids versus observation with oral steroids on an as needed basis, to see if either is useful in preventing future episodes of croup.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 31, 2012
CompletedFirst Posted
Study publicly available on registry
December 12, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedResults Posted
Study results publicly available
November 13, 2017
CompletedNovember 13, 2017
November 1, 2017
1.7 years
October 31, 2012
October 2, 2017
November 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quantity of Recurrent Episodes
Quantity of recurrent croup episodes experienced over a 1 year period by each participating subject.
1 year
Secondary Outcomes (1)
Severity of Croup Episodes
1 year
Study Arms (2)
Inhaled steroids
EXPERIMENTALDaily inhaled steroids. Fluticasone 2 puffs inhaled orally twice daily for six months.
Oral control
ACTIVE COMPARATORPatient and clinician observation with short term oral prednisolone as needed. Offered at 1mg/kg (body weight) daily dosing for symptomatic treatment on as needed basis for three days, but may be modified per managing physician's discretion.
Interventions
Daily inhaled steroids. Fluticasone 2 puffs inhaled orally twice daily for six months.
Eligibility Criteria
You may qualify if:
- Pediatric population: 6 months to 15 years of age
- or more episodes of croup in 12 month period
- croup defined as acute onset inspiratory stridor, barking cough, with respiratory distress.
You may not qualify if:
- Grade 3 or 4 subglottic stenosis
- Subglottic hemangioma
- Posterior laryngeal cleft
- Recurrent respiratory papillomatosis
- External compression (Innominate artery compression, mediastinal mass, (double aortic arch, etc)
- Symptoms or signs suggesting another cause of stridor, such as epiglottitis, bacterial tracheitis, or supraglottic foreign body
- Tracheomalacia/ bronchomalacia severe enough to cause respiratory distress
- Current steroid therapy for previously diagnosed condition, i.e. reactive airway disease.
- Other medical conditions necessitating chronic steroid utilization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. David J. Brown
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
David J Brown, MD
University of Michigan Department of Otolaryngology-Head & Neck Surgery
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Otorhinolaryngology
Study Record Dates
First Submitted
October 31, 2012
First Posted
December 12, 2012
Study Start
September 1, 2012
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
November 13, 2017
Results First Posted
November 13, 2017
Record last verified: 2017-11